Lori W. Barrentine, MS, PA-C
- 3Articles
- 28.1KReads
- 2013–2016Active
- 9Collaborators
- 104Citations
About
Lori W. Barrentine, MS, PA-C, has published research focusing on the treatment of major depressive disorder (MDD), particularly examining the use of l-methylfolate calcium as an adjunctive therapy with selective serotonin reuptake inhibitors. Her work includes studies on the long-term efficacy, safety, and tolerability of this treatment, as well as its effects in patients with obesity and inflammatory markers. Barrentine’s publications also explore real-world patient experiences with l-methylfolate in depression management.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
